Quantcast
Channel: Health Care RSS Feed
Viewing all articles
Browse latest Browse all 24638

Watertown’s Tetraphase says antibiotic clears late-stage hurdle

$
0
0
Watertown-based Tetraphase Pharmaceuticals said Tuesday it plans to seek FDA approval for one of its antibiotics early next year after the drug succeeded in a late-stage trial. Tetraphase (Nasdaq: TTPH) said the antibiotic, called eravacycline, was at least as effective as a commonly-prescribed antibiotic in treating complicated, intra-abdominal infections. There were no serious side effects observed in the 500-patient trial, the company said. Based on the results, Tetraphase, which had 66 employees…

Viewing all articles
Browse latest Browse all 24638

Trending Articles